• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期疫苗接种与 COVID-19 结局的关联:国家级分析。

Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.

机构信息

Pediatric Infectious Diseases Division, Seattle Children's Hospital, Seattle, WA, USA.

Department of Pediatrics, University of Washington, Seattle, WA, USA.

出版信息

Epidemiol Infect. 2021 Mar 16;149:e75. doi: 10.1017/S0950268821000571.

DOI:10.1017/S0950268821000571
PMID:33722335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8010281/
Abstract

We investigated whether countries with higher coverage of childhood live vaccines [BCG or measles-containing-vaccine (MCV)] have reduced risk of coronavirus disease 2019 (COVID-19)-related mortality, while accounting for known systems differences between countries. In this ecological study of 140 countries using publicly available national-level data, higher vaccine coverage, representing estimated proportion of people vaccinated during the last 14 years, was associated with lower COVID-19 deaths. The associations attenuated for both vaccine variables, and MCV coverage became no longer significant once adjusted for published estimates of the Healthcare access and quality index (HAQI), a validated summary score of healthcare quality indicators. The magnitude of association between BCG coverage and COVID-19 death rate varied according to HAQI, and MCV coverage had little effect on the association between BCG and COVID-19 deaths. While there are associations between live vaccine coverage and COVID-19 outcomes, the vaccine coverage variables themselves were strongly correlated with COVID-19 testing rate, HAQI and life expectancy. This suggests that the population-level associations may be further confounded by differences in structural health systems and policies. Cluster randomised studies of booster vaccines would be ideal to evaluate the efficacy of trained immunity in preventing COVID-19 infections and mortality in vaccinated populations and on community transmission.

摘要

我们研究了儿童期常规疫苗(卡介苗或含麻疹疫苗)覆盖率较高的国家是否降低了与 2019 年冠状病毒病(COVID-19)相关的死亡率,同时考虑到各国之间已知的系统差异。在这项针对 140 个国家的基于观察的研究中,我们利用了公开的国家级数据,疫苗覆盖率更高,代表过去 14 年期间接种疫苗的人数比例,与 COVID-19 死亡人数较低有关。这两种疫苗变量的相关性都减弱了,而且一旦根据医疗保健获取和质量指数(HAQI)的公布估计值进行调整,即医疗质量指标的综合得分,麻疹疫苗覆盖率就不再具有统计学意义。BCG 覆盖率与 COVID-19 死亡率之间的关联幅度根据 HAQI 而有所不同,而 MCV 覆盖率对 BCG 与 COVID-19 死亡之间的关联几乎没有影响。虽然活疫苗覆盖率与 COVID-19 结局之间存在关联,但疫苗覆盖率变量本身与 COVID-19 检测率、HAQI 和预期寿命密切相关。这表明,人群水平的关联可能因结构性卫生系统和政策的差异而进一步受到混杂。关于加强疫苗的随机对照试验将是评估训练免疫在预防接种人群中 COVID-19 感染和死亡率以及社区传播方面的疗效的理想方法。

相似文献

1
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.儿童期疫苗接种与 COVID-19 结局的关联:国家级分析。
Epidemiol Infect. 2021 Mar 16;149:e75. doi: 10.1017/S0950268821000571.
2
Association between live childhood vaccines and COVID-19 outcomes: a national-level analysis.儿童期活性疫苗与新冠病毒病结局之间的关联:一项国家级分析。
medRxiv. 2020 Oct 20:2020.10.17.20214510. doi: 10.1101/2020.10.17.20214510.
3
BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.巴西医护人员的卡介苗再接种以改善针对新冠病毒的先天免疫反应:一项随机对照试验研究方案的结构化总结
Trials. 2020 Oct 26;21(1):881. doi: 10.1186/s13063-020-04822-0.
4
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.重新利用儿童疫苗:我们能否训练免疫系统对抗 SARS-CoV-2。
Expert Rev Vaccines. 2021 Sep;20(9):1051-1057. doi: 10.1080/14760584.2021.1960161. Epub 2021 Aug 6.
5
Convergence between global BCG vaccination and COVID-19 pandemic.全球卡介苗接种与 COVID-19 大流行之间的趋同。
J Med Virol. 2021 Mar;93(3):1496-1505. doi: 10.1002/jmv.26450. Epub 2020 Sep 29.
6
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.COVID-19 大流行:SARS-CoV-2 特异性疫苗和挑战,BCG 训练免疫的保护作用,以及临床试验。
Expert Rev Vaccines. 2021 Jul;20(7):857-880. doi: 10.1080/14760584.2021.1938550. Epub 2021 Jun 15.
7
Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.加纳第二年儿童免疫接种:采取多方面方法的必要性。
Pan Afr Med J. 2017 Jun 21;27(Suppl 3):4. doi: 10.11604/pamj.supp.2017.27.3.12182. eCollection 2017.
8
Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.卡介苗(BCG)接种在 COVID-19 大流行死亡率中的潜在作用:流行病学和免疫学方面。
Asian Pac J Allergy Immunol. 2020 Sep;38(3):150-161. doi: 10.12932/AP-310520-0863.
9
Measles Vaccine Coverage and Disease Outbreaks: A Systematic Review of the Early Impact of COVID-19 in Low and Lower-Middle Income Countries.麻疹疫苗接种率和疾病暴发:COVID-19 对低收入和中低收入国家早期影响的系统评价。
Int J Public Health. 2024 Apr 25;69:1606997. doi: 10.3389/ijph.2024.1606997. eCollection 2024.
10
Are BCG-induced non-specific effects adequate to provide protection against COVID-19?BCG 诱导的非特异性效应是否足以提供针对 COVID-19 的保护?
Hum Vaccin Immunother. 2021 Jan 2;17(1):88-91. doi: 10.1080/21645515.2020.1794219. Epub 2020 Aug 7.

引用本文的文献

1
Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective.COVID-19 大流行对常规疫苗接种情况的影响:全球视角。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2199656. doi: 10.1080/21645515.2023.2199656. Epub 2023 Apr 20.
2
Effect of BCG on Respiratory Complications Caused by COVID-19: A Scoping Review.卡介苗对2019冠状病毒病所致呼吸并发症的影响:一项范围综述
Int J Gen Med. 2022 Dec 29;15:8727-8741. doi: 10.2147/IJGM.S393861. eCollection 2022.
3
Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review.卡介苗接种政策在降低 COVID-19 感染和死亡率方面的有效性:系统评价。
Glob Health Res Policy. 2022 Nov 7;7(1):42. doi: 10.1186/s41256-022-00275-x.
4
Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.虚假的早期生态学关联表明卡介苗接种对 COVID-19 的有效性。
PLoS One. 2022 Sep 20;17(9):e0274900. doi: 10.1371/journal.pone.0274900. eCollection 2022.
5
Measles, mumps and rubella vaccine and heterologous immunity: a way out of the COVID-19 crisis?麻疹、腮腺炎和风疹疫苗与异源免疫:摆脱新冠疫情危机的一条出路?
Sudan J Paediatr. 2022;22(1):10-18. doi: 10.24911/SJP.106-1621869672.
6
The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues.卡介苗接种对新冠病毒病的自然影响:争论仍在继续。
Front Immunol. 2022 Jul 8;13:953228. doi: 10.3389/fimmu.2022.953228. eCollection 2022.
7
BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.BCG 疫苗接种:对抗 COVID-19 和类似 COVID-19 的黑天鹅事件的潜在工具。
Int Immunopharmacol. 2022 Jul;108:108870. doi: 10.1016/j.intimp.2022.108870. Epub 2022 May 17.
8
COVID-19: Some unresolved issues.新型冠状病毒肺炎(COVID-19):一些未解决的问题。
Rev Esp Quimioter. 2022 Oct;35(5):421-434. doi: 10.37201/req/028.2022. Epub 2022 Apr 21.
9
COVID-19 susceptibility and vaccination coverage for measles, rubella and mumps in students and healthcare workers in Trieste hospitals (NE Italy).的里雅斯特医院(意大利东北部)学生和医护人员中新冠病毒易感性以及麻疹、风疹和腮腺炎疫苗接种覆盖率
Vaccine X. 2022 Feb 25;10:100147. doi: 10.1016/j.jvacx.2022.100147. eCollection 2022 Apr.
10
BCG vaccination at birth and COVID-19: a case-control study among U.S. military Veterans.出生时接种卡介苗与 COVID-19:美国退伍军人病例对照研究。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1981084. doi: 10.1080/21645515.2021.1981084. Epub 2021 Oct 13.

本文引用的文献

1
Suboptimal US Response to COVID-19 Despite Robust Capabilities and Resources.尽管具备强大的能力和资源,但美国对新冠疫情的应对仍未达最佳水平。
JAMA. 2020 Oct 13;324(14):1391-1392. doi: 10.1001/jama.2020.17395.
2
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.BCG 疫苗可能会产生针对 SARS-CoV-2 的交叉反应性 T 细胞:计算机分析与假设。
Vaccine. 2020 Sep 22;38(41):6352-6356. doi: 10.1016/j.vaccine.2020.08.045. Epub 2020 Aug 20.
3
Impact of Routine Infant BCG Vaccination on COVID-19.婴儿卡介苗常规接种对新冠病毒感染的影响。
J Infect. 2020 Oct;81(4):625-633. doi: 10.1016/j.jinf.2020.08.013. Epub 2020 Aug 12.
4
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).BCG 疫苗可预防严重的 2019 年冠状病毒病(COVID-19)。
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726. doi: 10.1073/pnas.2008410117. Epub 2020 Jul 9.
5
Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).别再摆弄数据了:目前没有可靠证据表明卡介苗能预防新型冠状病毒感染。
Acta Biomed. 2020 May 11;91(2):207-213. doi: 10.23750/abm.v91i2.9700.
6
BCG-induced trained immunity: can it offer protection against COVID-19?BCG 诱导的训练免疫:能提供针对 COVID-19 的保护吗?
Nat Rev Immunol. 2020 Jun;20(6):335-337. doi: 10.1038/s41577-020-0337-y.
7
Is BCG vaccination causally related to reduced COVID-19 mortality?BCG 疫苗接种是否与降低 COVID-19 死亡率有因果关系?
EMBO Mol Med. 2020 Jun 8;12(6):e12661. doi: 10.15252/emmm.202012661. Epub 2020 May 26.
8
Effect modification, interaction and mediation: an overview of theoretical insights for clinical investigators.效应修饰、交互作用和中介作用:临床研究者理论见解概述
Clin Epidemiol. 2017 Jun 8;9:331-338. doi: 10.2147/CLEP.S129728. eCollection 2017.
9
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.基于1990 - 2015年195个国家和地区可通过个人医疗保健预防的死因的医疗保健可及性和质量指数:全球疾病负担研究2015的一项新分析
Lancet. 2017 Jul 15;390(10091):231-266. doi: 10.1016/S0140-6736(17)30818-8. Epub 2017 May 18.
10
Commentary: BCG vaccination halves neonatal mortality.评论:卡介苗接种可使新生儿死亡率减半。
Pediatr Infect Dis J. 2012 Mar;31(3):308-9. doi: 10.1097/INF.0b013e3182465be8.